Activity of erythromycin on chlamydial strains recovered in pharynx: study on a pediatric group
Ottolenghi, A.; Magliano, E.; Clerici, P.; Finazzi, E.; De Chiara, A.
Chemioterapia International Journal of the Mediterranean Society of ChemoTherapy 6(2 Suppl): 157
1987
ISSN/ISBN: 0392-906X PMID: 3509375 Document Number: 301582
Document emailed within 1 workday
Related Documents
Vitali, C.; Bencivelli, W.; Isenberg, D.A.; Smolen, J.S.; Snaith, M.L.; Sciuto, M.; Neri, R.; Bombardieri, S. 1992: Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. II. Identification of the variables indicative of disease activity and their use in the development of an activity score. The European Consensus Study Group for Disease Activity in SLE Clinical and Experimental Rheumatology 10(5): 541-547Fiett, J.; Trzciński, K.; Hryniewicz, W.; Gniadkowski, M. 1998: The use of molecular biology in the modeling of Pseudomonas aeruginosa strains recovered from nosocomial infections Przeglad Epidemiologiczny 52(4): 427-440
Reina, J.; Serra, A.; Borrell, N.; Gómez, J. 1992: The suicide phenomenon and fermentative metabolic activity in strains of the Aeromonas group isolated from feces Enfermedades Infecciosas y Microbiologia Clinica 10(9): 536-538
Fujii, R.; Meguro, H.; Arimasu, O.; Tagaya, M.; Fujita, K.; Sakata, H.; Yoshioka, H.; Maruyama, S.; Sanae, N.; Nagamatsu, I. 1986: Bacteriological, pharmacokinetic and clinical evaluations of ceftriaxone in the pediatric field. Pediatric study group of ceftriaxone Japanese Journal of Antibiotics 39(8): 1988-2008
Bebora, L.C.; Oundo, J.O.; Yamamoto, H. 1994: Resistance of E. coli strains, recovered from chickens to antibiotics with particular reference to trimethoprim-sulfamethoxazole (septrin) East African Medical Journal 71(10): 624-627
Fujii, R.; Yoshioka, H.; Fujita, K.; Maruyama, S.; Sakata, H.; Inyaku, F.; Chiba, S.; Tsutsumi, H.; Wagatsuma, Y.; Fukushima, N. 1992: Pharmacokinetic and clinical studies with meropenem in the pediatric field. Pediatric Study Group of Meropenem Japanese Journal of Antibiotics 45(6): 697-717
Fujii, R.; Abe, T.; Tajima, T.; Terashima, I.; Meguro, H.; Nakazawa, S.; Sato, H.; Niinou, K.; Sunakawa, K.; Yokota, T. 1994: Pharmacokinetic and clinical studies with cefozopran in the pediatric field. Pediatric Study Group of Cefozopran Japanese Journal of Antibiotics 47(1): 102-123
Stephenson, E.H.; Storz, J. 1975: Protein profiles of dense-centered forms of five chlamydial strains of animal origin American Journal of Veterinary Research 36(7): 881-887
Oguike, J.U.; Gugnani, H.C.; Osuagwu, C. 1991: A note on penicillin resistance and beta-lactamase production in strains of Staphylococcus aureus recovered from different clinical materials in Nsukka, Nigeria Journal of Communicable Diseases 23(3): 200-201
Havlik, J.; Holý, M. 1976: Erythromycin stearate Spofa--coated tablets for pediatric practice Ceskoslovenska Pediatrie 31(7): 402-404
Lewis, M.; Colletti, R.B. 1973: Child psychiatry teaching in pediatric training: the use of a study group Pediatrics 52(5): 743-745
Ciepal, A.; Dzierzanowska, D.; Borowski, J. 1977: Studies of transmission of erythromycin and chlortetracycline resistance in group D streptococci Medycyna Doswiadczalna i Mikrobiologia 29(3): 161-165
Bhattacharyya, B.; Das, D.C.; Mukherjee, H.; Hati, A.K. 1992: A retrospective study on scorpion sting in a pediatric age group in a hospital in Calcutta Indian Journal of Medical Sciences 46(7): 205-208
Hansen, S.L.; Swomley, P.; Drusano, G. 1981: Effect of carbon dioxide and pH on susceptibility of Bacteroides fragilis group to erythromycin Antimicrobial Agents and Chemotherapy 19(2): 335-336
Yoshikawa, N.; Ito, H.; Sakai, T.; Takekoshi, Y.; Honda, M.; Awazu, M.; Ito, K.; Iitaka, K.; Koitabashi, Y.; Yamaoka, K.; Nakagawa, K.; Nakamura, H.; Matsuyama, S.; Seino, Y.; Takeda, N.; Hattori, S.; Ninomiya, M. 1997: A prospective controlled study of sairei-to in childhood IgA nephropathy with focal/minimal mesangial proliferation. Japanese Pediatric IgA Nephropathy Treatment Study Group Nihon Jinzo Gakkai Shi 39(5): 503-506
Brewer, E.J.; Giannini, E.H. 1982: Standard methodology for Segment I, II, and III Pediatric Rheumatology Collaborative Study Group studies. I. Design Journal of Rheumatology 9(1): 109-113
Mehanna, M.T.; Rizk, M.A.; Ramadan, M.; Schachter, J. 1994: Chlamydial serologic characteristics among intrauterine contraceptive device users: Does copper inhibit chlamydial infection in the female genital tract? American Journal of Obstetrics and Gynecology 171(3): 691-693
Binns, H.J.; LeBailly, S.A.; Poncher, J.; Kinsella, T.R.; Saunders, S.E. 1994: Is there lead in the suburbs? Risk assessment in Chicago suburban pediatric practices. Pediatric Practice Research Group Pediatrics 93(2): 164-171
Majer, J.; Stanaszek, R.S.; Mueller, S.L.; Marti, G. 1978: N-Didemethyl-n-propionyl-6,9;9, 12-erythromycin A-spiroketal, a new metabolite of erythromycin ethyl succinate in man Drug Metabolism and Disposition: the Biological Fate of Chemicals 6(6): 673-676
Klita, S.; Szafranśki, P. 1980: Comparison of the mechanism of action of cyclic 11,12-erythromycin a carbonate and erythromycin a Acta Biochimica Polonica 27(3-4): 213-220